PERTH, AUSTRALIA, January 25, 2011 - Phylogica Ltd
(ASX:PYC), (XETRA:PH7), a leading Australian drug discovery company, announced today that it has been named as one of the annual Bioshares ‘Tops 10 Picks’ of investment opportunities.
Bioshares is a leading Australian industry journal that provides independent investment analysis on the ASX biotechnology sector. The top ten stocks are chosen from more than 100 public companies on the basis that the shares are expected to outperform the market and post significant returns over a 12-month period. The full Bioshares article on Phylogica is available to download here: from the company’s
website:http://www.phylogica.com/display/index/analyst-coverage
-ends-
